AbbVie Other Countries — Net revenues remained flat by 0.0% to $1.44B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $1.36B to $1.44B. Over 4 years (FY 2021 to FY 2025), Other Countries — Net revenues shows an upward trend with a 4.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful market penetration or growing demand in smaller international territories, while a decrease may signal competitive pressure or economic headwinds in those regions.
This metric represents the total net sales generated from geographic regions outside of the company's primary reporting...
Comparable to 'Rest of World' or 'International' revenue segments reported by other multinational pharmaceutical companies, though the specific country composition varies by firm.
abbv_segment_all_other_countries_net_revenues| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $4.76B | $4.84B | $5.04B | $5.45B | $5.76B |
| YoY Change | — | +1.6% | +4.2% | +8.1% | +5.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.